Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1978 Aug;53(8):639–641. doi: 10.1136/adc.53.8.639

PABA screening test for exocrine pancreatic function in infants and children.

M Sacher, A Kobsa, D H Shmerling
PMCID: PMC1545053  PMID: 309317

Abstract

P-Amino-benzoic acid (PABA) is split specifically by pancreatic chymotrypsin from the synthetic tripeptide N-benzoyl-L-tyrosyl-PABA. The urinary excretion of absorbed PABA serves as an index for exocrine pancreatic function. The peptide (0.015 g/kg) was administered orally to 20 controls (aged between 5 months and 16 years), 6 patients with exocrine pancreatic insufficiency caused by cystic fibrosis (CF), and 9 newborn infants. In the controls the mean 6-hour PABA recovery was 58.5% (+/- 11.2 SD). Recovery in patients with CF was lower (P less than 0.001) with no overlap. In newborn infants the mean 6-hour PABA recovery was 23.4 (+/- 17.7 SD); overlapping in 3 instances with the results in CF patients. This simple, noninvasive test thus appears promising and merits further investigation in younger infants, especially newborns.

Full text

PDF
640

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvanitakis C., Greenberger N. J. Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function. Lancet. 1976 Mar 27;1(7961):663–666. doi: 10.1016/s0140-6736(76)92777-x. [DOI] [PubMed] [Google Scholar]
  2. Gyr K., Stalder G. A., Schiffmann I., Fehr C., Vonderschmitt D., Fahrlaender H. Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT). Gut. 1976 Jan;17(1):27–32. doi: 10.1136/gut.17.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gyr K., Wolf R. H., Imondi A. R., Felsenfeld O. Exocrine pancreatic function in protein-deficient patas monkeys studied by means of a test meal and an indirect pancreatic function test. Gastroenterology. 1975 Mar;68(3):488–494. [PubMed] [Google Scholar]
  4. Hadorn B., Zoppi G., Shmerling D. H., Prader A., McIntyre I., Anderson C. M. Quantitative assessment of exocrine pancreatic function in infants and children. J Pediatr. 1968 Jul;73(1):39–50. doi: 10.1016/s0022-3476(68)80037-x. [DOI] [PubMed] [Google Scholar]
  5. Imondi A. R., Stradley R. P., Wolgemuth R. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals. Gut. 1972 Sep;13(9):726–731. doi: 10.1136/gut.13.9.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Smith H. W., Finkelstein N., Aliminosa L., Crawford B., Graber M. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. J Clin Invest. 1945 May;24(3):388–404. doi: 10.1172/JCI101618. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES